MONTGOMERY, Ala. (AP) – With COVID-19 hospitalizations and cases on the rise in Alabama, the state will have a limited number of doses of a new drug that can be used to treat the illness, health officials said Thursday.
The state’s initial supply of 780 courses of the Pfizer oral drug Paxlovid, which the Food and Drug Administration approved for emergency use as the omicron variant spreads rapidly, will be distributed through pharmacies, the Department of Public Health said in a statement.
Dr. Scott Harris, the state health officer, said the drug will be available to people who aren’t hospitalized with the illness but isn’t a substitute for vaccinations, “which remain the best way for most people to protect themselves against severe illness and death due to COVID-19.”
“I continue to urge all Alabamians to be vaccinated and receive a booster dose when eligible,” Harris said.
Paxlovid, which will be available by prescription by the first week of January, was authorized for the treatment of mild-to-moderate COVID-19 symptoms in adults and children. Other states will also receive limited supplies before production and distribution increases, officials said.
